• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡及其对常见疾病的影响。

Ferroptosis and its impact on common diseases.

作者信息

Zou Pengjian, He Qiuming, Xia Huimin, Zhong Wei

机构信息

Department of Pediatric Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

出版信息

PeerJ. 2024 Dec 19;12:e18708. doi: 10.7717/peerj.18708. eCollection 2024.

DOI:10.7717/peerj.18708
PMID:39713140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11663406/
Abstract

Ferroptosis is a novel form of programmed cell death characterized by iron accumulation, lipid peroxidation, and a decline in antioxidant capacity, all of which are regulated by gene expression. The onset of numerous diseases is closely associated with ferroptosis. Common diseases affect a large population, reduce the quality of life, and impose an increased burden on the healthcare system. The role of ferroptosis in common diseases, its therapeutic potential, and even its translation into clinical drug treatments are currently significant research topics worldwide. This study preliminarily explores the theoretical basis of ferroptosis, its mechanism and treatment prospect in common diseases including ischaemia-reperfusion injury, inflammatory bowel diseases, liver fibrosis, acute kidney injury, diabetic kidney disease, stroke, Alzheimer's disease, cardiovascular disease, immune and cancer. This review provides a theoretical foundation for the further study and development of ferroptosis, as well as for the prevention and treatment of common diseases.

摘要

铁死亡是一种新型的程序性细胞死亡形式,其特征为铁蓄积、脂质过氧化和抗氧化能力下降,所有这些均受基因表达调控。众多疾病的发生都与铁死亡密切相关。常见疾病影响大量人群,降低生活质量,并给医疗系统带来日益加重的负担。铁死亡在常见疾病中的作用、其治疗潜力,甚至其转化为临床药物治疗,目前都是全球重要的研究课题。本研究初步探讨了铁死亡的理论基础、其在包括缺血再灌注损伤、炎症性肠病、肝纤维化、急性肾损伤、糖尿病肾病、中风、阿尔茨海默病、心血管疾病、免疫性疾病和癌症等常见疾病中的机制及治疗前景。本综述为铁死亡的进一步研究和开发以及常见疾病的预防和治疗提供了理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ea/11663406/d509963519b0/peerj-12-18708-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ea/11663406/d509963519b0/peerj-12-18708-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ea/11663406/d509963519b0/peerj-12-18708-g001.jpg

相似文献

1
Ferroptosis and its impact on common diseases.铁死亡及其对常见疾病的影响。
PeerJ. 2024 Dec 19;12:e18708. doi: 10.7717/peerj.18708. eCollection 2024.
2
Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease.铁死亡:胃肠道疾病的双刃剑。
Int J Mol Sci. 2021 Nov 17;22(22):12403. doi: 10.3390/ijms222212403.
3
Ferroptosis: past, present and future.铁死亡:过去、现在和未来。
Cell Death Dis. 2020 Feb 3;11(2):88. doi: 10.1038/s41419-020-2298-2.
4
Ferroptosis as an emerging target in inflammatory diseases.铁死亡作为炎症性疾病的一个新兴靶点。
Prog Biophys Mol Biol. 2020 Sep;155:20-28. doi: 10.1016/j.pbiomolbio.2020.04.001. Epub 2020 Apr 18.
5
MicroRNA-mediated regulation of Ferroptosis: Implications for disease pathogenesis and therapeutic interventions.微小RNA介导的铁死亡调控:对疾病发病机制和治疗干预的影响
Cell Signal. 2025 Jan;125:111503. doi: 10.1016/j.cellsig.2024.111503. Epub 2024 Nov 5.
6
Targeting ferroptosis by natural products in pathophysiological conditions.在病理生理条件下通过天然产物靶向铁死亡
Arch Toxicol. 2024 Oct;98(10):3191-3208. doi: 10.1007/s00204-024-03812-4. Epub 2024 Jul 10.
7
Augmenter of liver regeneration protects the kidney from ischaemia-reperfusion injury in ferroptosis.肝再生增强因子通过铁死亡途径保护肾脏免于缺血再灌注损伤。
J Cell Mol Med. 2019 Jun;23(6):4153-4164. doi: 10.1111/jcmm.14302. Epub 2019 Apr 16.
8
Molecular mechanisms of ferroptosis in cardiovascular disease.铁死亡在心血管疾病中的分子机制。
Mol Cell Biochem. 2024 Dec;479(12):3181-3193. doi: 10.1007/s11010-024-04940-2. Epub 2024 Feb 19.
9
Ferroptosis in organ ischemia-reperfusion injuries: recent advancements and strategies.器官缺血再灌注损伤中的铁死亡:最新进展与策略
Mol Cell Biochem. 2025 Jan;480(1):19-41. doi: 10.1007/s11010-024-04978-2. Epub 2024 Mar 31.
10
The role of ferroptosis in acute kidney injury: mechanisms and potential therapeutic targets.铁死亡在急性肾损伤中的作用:机制与潜在治疗靶点
Mol Cell Biochem. 2025 Feb;480(2):759-784. doi: 10.1007/s11010-024-05056-3. Epub 2024 Jun 28.

引用本文的文献

1
Emerging dual role of ferroptosis in lung cancer (Review).铁死亡在肺癌中的新兴双重作用(综述)
Oncol Rep. 2025 Nov;54(5). doi: 10.3892/or.2025.8974. Epub 2025 Aug 24.

本文引用的文献

1
Blood brain barrier-targeted delivery of double selenium nanospheres ameliorates neural ferroptosis in Alzheimer's disease.双硒纳米球的血脑屏障靶向递送改善阿尔茨海默病中的神经铁死亡。
Biomaterials. 2023 Oct 22;302:122359. doi: 10.1016/j.biomaterials.2023.122359.
2
A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4.一种新型的铁死亡抑制剂,通宁甲素 A,通过激活 GPX4 来改善阿尔茨海默病。
Theranostics. 2024 Sep 23;14(16):6161-6184. doi: 10.7150/thno.98172. eCollection 2024.
3
Dual-responsive renal injury cells targeting nanoparticles for vitamin E delivery to treat ischemia reperfusion-induced acute kidney injury.
用于维生素 E 递送的双重响应性肾损伤细胞靶向纳米颗粒治疗缺血再灌注诱导的急性肾损伤。
J Nanobiotechnology. 2024 Oct 15;22(1):626. doi: 10.1186/s12951-024-02894-7.
4
Glutathione-Depleted Photodynamic Nanoadjuvant for Triggering Nonferrous Ferroptosis to Amplify Radiotherapy of Breast Cancer.用于引发非铁性铁死亡以增强乳腺癌放疗的谷胱甘肽耗尽型光动力纳米佐剂
Adv Healthc Mater. 2024 Dec;13(31):e2402474. doi: 10.1002/adhm.202402474. Epub 2024 Oct 13.
5
Augmented the sensitivity of photothermal-ferroptosis therapy in triple-negative breast cancer through mitochondria-targeted nanoreactor.通过线粒体靶向纳米反应器提高三阴性乳腺癌光热-铁死亡治疗的敏感性。
J Control Release. 2024 Nov;375:733-744. doi: 10.1016/j.jconrel.2024.09.042. Epub 2024 Sep 28.
6
The role of glutathione peroxidase 4 in neuronal ferroptosis and its therapeutic potential in ischemic and hemorrhagic stroke.谷胱甘肽过氧化物酶 4 在神经元铁死亡中的作用及其在缺血性和出血性中风中的治疗潜力。
Brain Res Bull. 2024 Oct 15;217:111065. doi: 10.1016/j.brainresbull.2024.111065. Epub 2024 Sep 6.
7
Ferroptosis-targeting drugs in breast cancer.乳腺癌中靶向铁死亡的药物
J Drug Target. 2025 Jan;33(1):42-59. doi: 10.1080/1061186X.2024.2399181. Epub 2024 Sep 5.
8
BSA-stabilized selenium nanoparticles ameliorate intracerebral hemorrhage's-like pathology by inhibiting ferroptosis-mediated neurotoxicology via Nrf2/GPX4 axis activation.BSA 稳定的硒纳米颗粒通过激活 Nrf2/GPX4 轴抑制铁死亡介导的神经毒性来改善脑出血样病变。
Redox Biol. 2024 Sep;75:103268. doi: 10.1016/j.redox.2024.103268. Epub 2024 Jul 17.
9
Ginsenoside Rg1 mitigates cerebral ischaemia/reperfusion injury in mice by inhibiting autophagy through activation of mTOR signalling.人参皂苷 Rg1 通过激活 mTOR 信号通路抑制自噬减轻小鼠脑缺血/再灌注损伤。
Acta Pharmacol Sin. 2024 Dec;45(12):2474-2486. doi: 10.1038/s41401-024-01334-4. Epub 2024 Jun 27.
10
Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1/SLC7A11 axis.人参皂苷Rb1通过BECN1/SLC7A11轴诱导肝星状细胞铁死亡以减轻肝纤维化。
J Pharm Anal. 2024 May;14(5):100902. doi: 10.1016/j.jpha.2023.11.009. Epub 2023 Nov 29.